HealthEquity, Inc. $HQY Stock Sold by Physician Wealth Advisors Inc.

Physician Wealth Advisors Inc. lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 38.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 28,862 shares of the company’s stock after selling 18,183 shares during the quarter. Physician Wealth Advisors Inc.’s holdings in HealthEquity were worth $2,553,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. BlackRock Inc. bought a new position in HealthEquity in the 2nd quarter valued at approximately $1,018,621,000. Wasatch Advisors LP grew its holdings in HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after acquiring an additional 757,801 shares during the last quarter. William Blair Investment Management LLC bought a new stake in HealthEquity during the 2nd quarter worth approximately $160,158,000. Dimensional Fund Advisors LP grew its holdings in HealthEquity by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock worth $135,957,000 after acquiring an additional 45,287 shares during the last quarter. Finally, Bank of America Corp DE acquired a new position in HealthEquity in the 2nd quarter valued at approximately $103,573,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a research report on Thursday, September 3rd. BTIG Research restated a “buy” rating and issued a $115.00 price target on shares of HealthEquity in a research report on Friday, August 28th. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. Finally, Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $112.20.

Insider Buying and Selling

In related news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company’s stock.

HealthEquity Stock Up 3.8%

Shares of NASDAQ HQY opened at $96.60 on Wednesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The company has a 50-day moving average price of $95.62 and a 200-day moving average price of $91.63. The stock has a market capitalization of $7.99 billion, a P/E ratio of 34.87, a P/E/G ratio of 1.47 and a beta of 0.24. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $107.62.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.19 by $0.05. The firm had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The firm’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.